agilon health, inc. (AGL)
NYSE: AGL · Real-Time Price · USD
0.572
-0.093 (-13.92%)
Mar 6, 2026, 3:27 PM EST - Market open

agilon health Stock Forecast

Stock Price Forecast

The 11 analysts with 12-month price forecasts for agilon health stock have an average target of 2.66, with a low estimate of 0.50 and a high estimate of 7.50. The average target predicts an increase of 365.03% from the current stock price of 0.57.

Analyst Consensus: Hold
Target Low Average Median High
Price $0.50 $2.66 $1.50 $7.50
Change -12.59% +365.03% +162.24% +1211.2%

Analyst Ratings

The average analyst rating for agilon health stock from 14 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating Oct '25Nov '25Dec '25Jan '26Feb '26Mar '26
Strong Buy 111111
Buy 333322
Hold 151513131010
Sell 111111
Strong Sell 000000
Total 202018181414

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Citigroup
Citigroup
Hold
Maintains
$0.85$0.75
Hold Maintains $0.85$0.75 +31.12% Mar 3, 2026
Wells Fargo
Wells Fargo
Buy
Maintains
$1$1.5
Buy Maintains $1$1.5 +162.24% Feb 27, 2026
Barclays
Barclays
Sell
Maintains
$1$0.5
Sell Maintains $1$0.5 -12.59% Feb 27, 2026
BTIG
BTIG
Hold
Suspends
n/a
Hold Suspends n/a n/a Dec 12, 2025
Barclays
Barclays
Sell
Maintains
$1.5$1
Sell Maintains $1.5$1 +74.83% Nov 6, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
5.73B
from 5.93B
Decreased by -3.36%
Revenue Next Year
6.14B
from 5.73B
Increased by 7.17%
EPS This Year
-0.35
from -0.95
EPS Next Year
-0.22
from -0.35
Fiscal Year FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
1.52B2.39B4.32B6.06B5.93B5.73B6.14B
Revenue Growth
24.88%56.97%80.74%40.41%-2.11%-3.36%7.17%
EPS
-1.09-0.26-0.64-0.63-0.95-0.35-0.22
EPS Growth
-------
Forward PE
-------
No. Analysts -----1815
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20262027202820292030
High 6.5B 7.4B
Avg 5.7B 6.1B
Low 5.3B 5.3B

Revenue Growth

Revenue Growth 20262027202820292030
High
10.1%
29.3%
Avg
-3.4%
7.2%
Low
-10.6%
-8.2%

EPS Forecast

EPS 202620272028
High -0.19 -0.05
Avg -0.35 -0.22
Low -0.51 -0.40

EPS Growth

EPS Growth 202620272028
High - -
Avg - -
Low - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.